Global Left Atrial Appendage Closure Devices market is poised to experience a stellar growth through 2032. The growth can be ascribed to a host of novel product innovations and rising government initiatives to increase the awareness for atrial fibrillation among the geriatric population.
Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/3960
In 2022, Abbott Laboratories announced the U.S. availability of its Amplatzer Steerable Delivery Sheath used with Amplatzer Amulet Left Atrial Appendage Occluder to cure patients with AFib. The recent inclusion to Abbott's portfolio demonstrates the firm's commitment to innovating across heart ailments, including left atrial appendage closure.
The elevating geriatric population worldwide is also likely to contribute to the growth trajectory of left atrial appendage closure devices industry over 2023-3032. According to the WHO estimates, the number of persons aged 80 years and above is anticipated to triple between 2020 and 2050, reaching 426 million by 2050 end.
Overall, the left atrial appendage closure devices market landscape is bifurcated in terms of products, procedure, end-use, and regions.
On the basis of product, the endocardial LAA closure devices segment is slated to gain considerable returns by 2032. Factors like growing awareness regarding the advantages offered by endocardial LAA devices and the increasing demand in treatment of AFib would support the segmental expansion. In addition, the devices have been recognized to avert the risk of thromboembolic events with acceptable procedure-related complications.
Considering the procedure, the LAA closure devices market share from surgical procedure segment would account for appreciable growth during 2023-2032. The progression is driven by the merits offered by surgical LAA closure devices in LAA closure procedures. The effectiveness of the equipment depends fundamentally on their ability to sustain a high occlusion pressure compared to stapling and suture ligation. Besides, the approach delivers an opportunity to prevent systemic anticoagulation, thus reducing the risk of bleeding.
Based on end-use, hospitals are expected to acquire a substantial business share through 2032 fueled by the mounting use of LAA closure devices in hospital setting for surgical procedures. Presence of highly skilled medical professionals, growing disease screening initiatives, and optimum patient care in hospitals would further propel the segmental expansion.
On the regional purview, Europe left atrial appendage closure devices market would record noteworthy gains between 2023-2032. Elevating elderly population graph in the continent is one of the prominent factors stimulating the regional progression. According to Eurostat statistics, there will be nearly half a million centenarians in the EU-27 by 2050 end.
Moreover, expanding prevalence of AFib in the older population in Europe would contribute to the regional LAA closure devices market growth. The prevalence of atrial fibrillation among individuals older than 55 years is predicted to reach 14 million by 2060, as stated by a recent study.
Some of the prominent companies operating in global left atrial appendage closure devices industry are Abbott Laboratories, Boston Scientific Corporation, Johnson and Johnson, AtriCure, and others. These companies are strategically involved in partnerships, mergers and acquisitions, and product launches to gain a competitive edge in the overall market.
Request for customization @ https://www.gminsights.com/roc/3960
Table of Contents (ToC) of the report:
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates and working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Business trends
2.2 Product trends
2.3 Procedure trends
2.4 End-use trends
2.5 Regional trends
Browse complete Table of Contents (ToC) of this research report @ https://www.gminsights.com/toc/detail/left-atrial-appendage-closure-devices-market
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Aashit Tiwari
Corporate Sales, USA
Global Market Insights Inc.
Toll Free: 1-888-689-0688
USA: +1-302-846-7766
Europe: +44-742-759-8484
APAC: +65-3129-7718
Email:[email protected]
The Left Atrial Appendage Closure Device Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the left atrial appendage closure device market include Boston Scientific Corporation, AtriCure, St. Jude Medical, Lifetech Scientific (Shenzhen), Coherex Medical.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Left Atrial Appendage Closure Device Market Research Report" by requesting FREE Sample Copy athttps://www.valuemarketresearch.com/contact/left-atrial-appendage-closure-device-market/download-sampleMarket DynamicsStroke is a serious risk for patients with atrial fibrillation.
Atrial fibrillation (AFib) is the most widely recognized heart rhythm abnormality, affecting more than 33 million individuals around the world.
Also, Surge in government initiatives to raise public awareness related to cardiovascular diseases and attractive health insurance policies are likely to influence the growth of left atrial appendage closure device market.
Left Atrial Appendage Closure Device Market report published by Value Market Research, which studies the future outlook of the market.
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the left atrial appendage closure device market include Boston Scientific Corporation, AtriCure, St. Jude Medical, Lifetech Scientific (Shenzhen), Coherex Medical.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Left Atrial Appendage Closure Device Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/left-atrial-appendage-closure-device-market/download-sampleMarket DynamicsStroke is a serious risk for patients with atrial fibrillation.
Atrial fibrillation (AFib) is the most widely recognized heart rhythm abnormality, affecting more than 33 million individuals around the world.
Also, Surge in government initiatives to raise public awareness related to cardiovascular diseases and attractive health insurance policies are likely to influence the growth of left atrial appendage closure device market.
